01 1Aurobindo Pharma Limited
01 1RABEPRAZOLE SODIUM
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-08-21
Pay. Date : 2013-05-21
DMF Number : 19186
Submission : 2006-01-31
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RABEPRAZOLE SODIUM, with a corresponding US DMF Number 19186.
Remarkably, this DMF maintains an Active status since its submission on January 31, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 21, 2013, and payment made on May 21, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
